Versant Capital Management, Inc Kura Oncology, Inc. Transaction History
Versant Capital Management, Inc
- $710 Million
- Q3 2025
A detailed history of Versant Capital Management, Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Versant Capital Management, Inc holds 1,272 shares of KURA stock, worth $13,279. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,272
Previous 1,236
2.91%
Holding current value
$13,279
Previous $7,000
57.14%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding KURA
# of Institutions
200Shares Held
80.6MCall Options Held
53.6KPut Options Held
42.8K-
Suvretta Capital Management, LLC New York, NY8.12MShares$84.7 Million1.61% of portfolio
-
Bvf Inc San Francisco, CA7.75MShares$81 Million1.76% of portfolio
-
Black Rock Inc. New York, NY6.97MShares$72.7 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY6.2MShares$64.7 Million0.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$55.8 Million0.0% of portfolio
About Kura Oncology, Inc.
- Ticker KURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 66,893,000
- Market Cap $698M
- Description
- Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...